First Manhattan’s Mesoblast MESO Stock Holding History

First Manhattan’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100	Closed	-$1K	–	1634
2021 Q3	$1K	Hold	100	–	–	﹤0.01%	1553
2021 Q2	$1K	Hold	100	–	–	﹤0.01%	1534
2021 Q1	$1K	Hold	100	–	–	﹤0.01%	1441
2020 Q4	$1K	Sell	100 -400	-80%	-$9.85K	﹤0.01%	1303
2020 Q3	$18K	Buy	+500	New	+$15.7K	﹤0.01%	1041

Other funds holding MESO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

First Manhattan's MESO Position: Q4 2021 in Review

First Manhattan sold out of Mesoblast (MESO) in Q4 2021, closing a stake of 100 shares — an estimated $1K sold.

First Manhattan first reported a position in MESO in Q3 2020 and held it in 5 quarters. The position peaked at $18K in Q3 2020. 42 funds tracked by Wall St. Rank hold MESO as of Q4 2021.

First Manhattan reported no remaining Mesoblast position as of Q4 2021 after selling out during the quarter.
First Manhattan sold 100 Mesoblast shares in Q4 2021, an estimated $1K.
First Manhattan first reported a position in Mesoblast in Q3 2020 and held it in 5 quarters.
First Manhattan's Mesoblast position peaked at $18K in Q3 2020.
42 funds tracked by Wall St. Rank held Mesoblast as of Q4 2021.

Based on First Manhattan's 13F filing for Q4 2021, filed 14 Feb 2022.